ARGENTA ADVISORS
Live / Registered — Registered and renewed (as of 01 Jul 2025)
What this means for you
Registered since 17 Feb 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Feb 2025).
Record
- Serial number
- 86225969
- Registration number
- 4687306
- Mark type
- Stylized text
- Filed
- 19 Mar 2014
- Published for opposition
- 02 Dec 2014
- Registered
- 17 Feb 2015
- Next maintenance due
- 17 Feb 2025
- Attorney of record
- Matthew Saunders
Goods and services
- Class 035 — Advertising and business services: Business consulting and advisory services in the fields of medical technology, biotechnology, and pharmaceuticals; Business consulting and advisory services in the fields of medical technology, biotechnology, and pharmaceuticals, namely, evaluation and assessment of reimbursement availability and strategies to maximize reimbursement for healthcare services; Business consulting and advisory services in the field of market adoption of medical, biotechnical, and pharmaceutical products; Business consulting and advisory services in the field of technology assessment, insurance payer coverage, and medical policy development; Business consulting and advisory services in the field of medical coding and billing; Business research using focus groups; Conducting business and market research in the field of healthcare using focus groups; Business consulting and advisory services in the field of clinical trial design; Market research and market intelligence services in the field of health care reimbursement; Reimbursement consulting and advisory services to the medical technology, biotechnology, and pharmaceuticals industries in the nature of analyzing health care policies and insurance reimbursement policies and evaluating product cost-effectiveness for the purposes of product development, product approval and market adoption; Reimbursement consulting and advisory services to the medical technology, biotechnology, and pharmaceuticals industries, namely, providing analysis of health care policies and insurance reimbursement policies and product cost-effectiveness for the purposes of product development, product approval and market adoption; Reimbursement consulting and advisory services in the field of market adoption of medical, biotechnological, and pharmaceutical products
Owner
- ARGENTA ADVISORS, INC., Quincy, MA, US
- Argenta Advisors LLC, St. Paul, MN, US
- Argenta Advisors LLC, St. Paul, MN, US
- Argenta Advisors LLC, St. Paul, MN, US
Prior registrations
Prosecution history
- 01 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 01 Jul 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 01 Jul 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 30 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jan 2025 — TEAS SECTION 8 & 9 RECEIVED
- 17 Feb 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 16 Apr 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Apr 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 16 Apr 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Dec 2020 — TEAS SECTION 8 & 15 RECEIVED
- 17 Feb 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Feb 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Feb 2015 — REGISTERED-PRINCIPAL REGISTER
- 02 Dec 2014 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2014 — PUBLISHED FOR OPPOSITION